• 1. Department of Ophthalmology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China;
  • 2. Senior Department of Ophthalmology, The Chinese PLA General Hospital, Beijing 100853, China;
Wei Shihui, Email: weishihui706@hotmail.com
Export PDF Favorites Scan Get Citation

The early diagnosis of increased intracranial pressure is of great value for the prognosis of neurological diseases. Non-invasive ocular multimodal imaging methods for intracranial pressure monitoring include optic nerve sheath diameter measurement and optical coherence tomography (OCT). Optic nerve sheath diameter measurement is the most convenient and efficient, and OCT has also been proven applicable for the early differentiation of papilledema associated with increased intracranial pressure. This editorial aims to detail the clinical value, diagnostic efficacy, and application scenarios of three imaging methods for optic nerve sheath diameter measurement and OCT in predicting increased intracranial pressure, clarifying that multimodal imaging methods help improve the monitoring system for increased intracranial pressure and provide guidance for early screening of intracranial pressure elevation. Given the promising application prospects of multimodal imaging in ophthalmology, it is suggested that ophthalmologists pay more attention to optic nerve sheath diameter and OCT results when facing patients suspected of having increased intracranial pressure, and conduct relevant basic and clinical research to further explore the application value of multimodal imaging in different age and disease conditions.

Citation: Fu Tao, Wei Shihui. Pay attention to the application of multimodal imaging methods in the evaluation of increased intracranial pressure. Chinese Journal of Ocular Fundus Diseases, 2026, 42(2): 99-106. doi: 10.3760/cma.j.cn511434-20260108-00023 Copy

Copyright ? the editorial department of Chinese Journal of Ocular Fundus Diseases of West China Medical Publisher. All rights reserved

  • Previous Article

    Research progress in the treatment of primary vitreoretinal lymphoma